Technology Solutions

BRANY launches new license option for Protocol Builder

Friday, August 14, 2015

Protocol Builder, a cloud-based solution for investigator-initiated clinical trials, now is available to individual researchers, including medical residents and fellows, according to the Biomedical Research Alliance of New York (BRANY), the developer of the system and a national organization providing clinical research support solutions such as IRB review, trial contracting/budgeting, and auditing and monitoring to hospitals and academic medical centers.

[Read More]

Roche acquires GeneWEAVE

Thursday, August 13, 2015

Roche has signed a definitive agreement to acquire GeneWEAVE BioSciences, a Los Gatos, Calif.-based, privately held company focused on clinical microbiology diagnostics solutions. Roche will pay GeneWEAVE shareholders $190 million upfront and up to $235 million in contingent product related milestones. The transaction is subject to customary closing conditions and, once closed, GeneWEAVE will be integrated into Roche Molecular Diagnostics.

[Read More]

Survey: Industry will move toward RBM adoption

Wednesday, August 12, 2015

OmniComm Systems, a global provider of clinical data management technology, has announced survey results representing clinical research and development organizations. The survey respondents included 16 sponsor organizations and 13 CROs. The results indicate a significant movement forward in the industry toward active risk-based monitoring (RBM) adoption, with 76% of the organizations reporting that they are either already executing RBM studies (45%) or planning to initiate RBM studies during this year (31%).

[Read More]

CRF Health launches eCOA solution for oncology trials

Wednesday, August 12, 2015

CRF Health, a Plymouth Meeting, Pa.-based global provider of electronic Clinical Outcome Assessment (eCOA) solutions for the life sciences industry, has launched a complete TrialMax eCOA solution specifically for oncology clinical trials. Developed based on CRF Health’s experience of delivering more than 100 global oncology studies, the solution streamlines data collection by combining an eCOA capture system with intuitive site and patient management tools. Reporting concomitant medication data also is simplified, enabling sponsors to collect complete data while reducing patient and investigator burden.

[Read More]

Algorithm changes name, updates acuity solution

Monday, August 10, 2015

Algorithm, a global provider of clinical analytics solutions and software, has released the latest version of its acuity solution, designed for use by pharma, biotech, CRO and academic organizations to drive regulatory compliant processes around management of risk. The acuity solution allows organizations to assess and capture the risk profile for a clinical trial and map risks to intelligent actions as part of the risk-based monitoring paradigm.

[Read More]

iCardiac acquires nSpire Health’s clinical trials division

Thursday, August 6, 2015

iCardiac Technologies, a Rochester, N.Y.-based global provider of cardiac safety assessment services to the pharmaceutical industry, has added respiratory and ePRO services to its suite of offerings through the acquisition of the clinical trials division of nSpire Health. iCardiac also has opened a new office in Longmont, Colo., to accommodate the project management, data management, customer support, IT, technology development and business development teams joining iCardiac from nSpire Health.

[Read More]

Certara launches Simcyp In Vitro (Data) Analysis Toolkit

Wednesday, July 29, 2015

Certara, a Princeton, N.J.-based, global biosimulation technology-enabled drug development company, launched its Simcyp In Vitro (Data) Analysis (SIVA) Toolkit, version 1.0. The SIVA Toolkit is designed to enable the analysis of complex in vitro studies, including those with whole cells, tissue samples and solid dosage forms. It combines the latest model-based data analysis approaches to assess the metabolism, transport or dissolution/solubility of drugs with powerful optimization algorithms in a sophisticated statistical environment. This approach ensures that users do not need to have extensive modeling or statistical experience to use the toolkit.

[Read More]